Skip to Main Content
Yale Institute for Global Health
Yale Home

INFORMATION FOR

    COVID-19 Vaccine | Infectious Diseases, Phase III

    The TIPI Study

    What is the purpose of this trial?

    The purpose of this research is to find out if a single dose of pre-travel vaccination with BCG (a living organism preparation) can lessen Tuberculosis (TB) infection by producing an immune response (development of TB fighter cells within the body) when given to adults traveling to countries with a high burden of TB. BCG will be compared with a placebo (an inactive vaccine). Participants will be randomly assigned (this is like a coin flip) to receive BCG vaccine or placebo.

    • Ages
      18 years - 65 years
    • Gender
      Both
    Find out more about who can participate in this trial

    Contact Information

    For more information about this study, including how to volunteer, contact Anousheh Behnegar

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    Create a volunteer profile

    Principal Investigator

    • Last Updated
      01/04/2026
    • Study HIC
      #2000028329

    Contact Information

    For more information about this study, including how to volunteer, contact Anousheh Behnegar